Texas Testosterone LawyerYou have probably seen advertisements for treating low testosterone, or “Low T,” with patches, injections, or gels like AndroGel. These testosterone treatments are aggressively marketed to men with flagging libidos, sagging muscles, and low energy — but new studies show that testosterone therapy in older men may double or even triple the risk of heart attacks, blood clots, stroke, pulmonary embolism, and other deadly side effects.

Need a Texas Testosterone Lawyer? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you or a loved one was injured by testosterone therapy heart attack or other side effect, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit in Texas or joining a class action.

UPDATE: 1st Trial Set for July 2017

August 9, 2016 — Judge Kennelly set the first “bellwether” trial date for July 2017 and picked a case involving a man from Tennessee who had a heart attack after taking AndroGel. Click here to read more.

July 6, 2016 — Testosterone therapy is being promoted for aging men with naturally declining libido, according to an investigation into “illness inflation.” Click here to read more.

May 2, 2016 — A new study has found that mice who were given testosterone had more calcification in their arteries, which is a major risk-factor for heart disease. Click here to read more.

April 15, 2016 — Over 5,250 lawsuits have been filed by men who suffered cardiovascular events after using testosterone replacement products like Androgel. The lawsuits have been centralized in MDL No. 2545 under District Judge Matthew F. Kennelly in the Northern District of Illinois. Click here to read more.

November 13, 2015 — A federal judge has rejected failure-to-warn claims involving Testopel and Depo-Testosterone because drug-makers did not have the authority to unilaterally strengthen the labels. Click here to read more.

October 19, 2015 — Industry-funded continuing medical education (CME) courses promoted testosterone for “off-label” purposes, according to a new investigation. Click here to read more.

October 7, 2015 — Lawyers have until the end of the month to choose a pool of 32 cases for the first six trials, set to begin in October 2016. Click here to read more.

August 12, 2015 — A study published in JAMA has found that testosterone therapy does not appear to cause atherosclerosis, a major risk-factor for cardiovascular events, but it also does not seem to improve sexual health or overall quality of life. Click here to read more.

July 20, 2015 — Over 2,000 lawsuits involving side effects of testosterone have been filed, but a new study has found no link between testosterone therapy and venous thromboembolism (VTE). Click here to read more.

June 17, 2015 — A growing number of experts are calling out pharmaceutical companies for engaging in “disease mongering” to promote testosterone therapy for common, non-specific age-related symptoms. Click here to read more.

May 20, 2015 — A new study suggests that injections of testosterone (such as Depo-Tetsosterone) may spike a man’s risk of heart attack, stroke, and death compared to topical gel products like AndroGel, which are absorbed slowly through the skin. Click here to read more.

May 5, 2015 — A lawsuit has been filed by a man from New York who developed blood clots in his legs after using Depo-Testosterone. Click here to read more.

April 10, 2015 — Within less than a year, over 1,340 angry men who say they were injured by testosterone products like AndroGel have filed lawsuits against manufacturers in federal court. Click here to read more.

March 4, 2015 — In a Safety Communication, the FDA is asking manufacturers of testosterone replacement products to stop marketing them for the treatment of age-related “Low T,” add warnings about heart attacks and strokes, and start studying the long-term risks. Click here to read more.

January 14, 2015 — Pharmacotherapy has published a study linking the first-time use of testosterone replacement therapy with a 41% increased risk of heart attack compared to non-users, and even higher risks for men with coronary artery disease. Click here to read more.

January 7, 2015 — The number of lawsuits involving testosterone replacement products has nearly reached 300, with two new cases filed this week in a centralized federal litigation in Illinois. Click here to read more.

November 6, 2014 — AbbVie, Inc., manufacturer of the blockbuster testosterone gel product AndroGel, has reported consistently falling sales figures since last year. Click here to read more.

October 20, 2014 — Endocrinology has published a stduy in rodents that found a higher risk of prostate cancer when they were given testosterone replacement therapy. Click here to read more.

October 2, 2014 — The New Jersey Law Journal reports that Eli Lilly & Co. has been hit with a lawsuit from a man who used Axiron (testosterone gel) and suffered a heart attack. Click here to read more.

September 18, 2014 — An expert panel of advisors to the FDA has overwhelmingly voted in favor of restricting the labels on testosterone treatment to clarify that the drugs are only for patients who have been diagnosed with hypogonadism. According to one expert, “The whole idea is to try to rein in the inappropriate advertising and use of these drugs.” Click here to read more.

September 17, 2014 — New York Times reports that an advisory panel of experts is meeting today to discuss whether to recommend regulatory action from the FDA to restrict testosterone therapy for “age-related hypogonadism.” Click here to read more.

September 12, 2014 — There is little evidence of any benefit from testosterone therapy in aging men, but the safety risks are also unclear, according to an FDA report (PDF) published ahead of an advisory panel meeting on September 17. Click here to read more.

August 22, 2014 — A lawsuit (PDF) has been filed on behalf of a man from California who used Depo-Testosterone and suffered severe heart problems. Click here to read more.

August 15, 2014 — A complaint has been filed against the Journal of American Medical Association (JAMA) for publishing a study linking testosterone therapy with a 30% increased risk of heart attack, stroke, and death. Click here to read more.

July 25, 2014 — Attorneys in Canada have filed two class action lawsuits against the manufacturers of AndroGel (testosterone gel) and Delatestryl (testosterone injection). Click here to read more.

July 21, 2014 — Health Canada is warning about a “growing body of evidence” linking testosterone and heart problems, including blood clots in the lungs or legs, heart attack, stroke, and a heart rhythm that is irregular or fast. Click here to read more.

July 3, 2014 — A study published in the Annals of Pharmacotherapy has found no link between testosterone and heart attacks after evaluating data on older men who received intramuscular injections of testosterone. Click here to read more.

June 20, 2014 — FDA has published a Safety Communication requiring manufacturers of all testosterone replacement products to add warnings about the risk of venous blood clot complications, including pulmonary embolism (PE), deep vein thrombosis (DVT), and venous thromboembolism (VTE). Click here to read more.

June 6, 2014 — Federal judges have decided to centralize lawsuits involving testosterone replacement products into one federal court. The Multi-District Litigation (MDL) will be located in the U.S. District Court for the Northern District of Illinois, overseen by Judge Matthew F. Kennelly. At least 45 actions will be transferred into the litigation. Click here to read more.

June 4, 2014 — A man from Texas has filed a lawsuit against AbbVie, alleging that his heart attack was caused by AndroGel. The plaintiff, David Lyon, filed a lawsuit (PDF) this week in federal court in Illinois. Click here to read more.

May 22, 2014 — AbbVie is facing a rapidly growing number of lawsuits from men who were injured by AndroGel. The most recent claims involve heart attacks, stroke, and wrongful death. Click here to read more.

May 14, 2014 — Law360 reports that one of the first lawsuits involving Fortesta has been filed in Pennsylvania against Endo Pharmaceuticals Inc. and U.K.-based Prostrakan Group PLC. The plaintiffs, Demetric Taylor and his wife, allege that Fortesta is responsible for his heart attack. Click here to read more.

April 30, 2014 — Dr. Stephanie Page, professor at the University of Washington Harborview Medical Center, has published an editorial The Lancet Diabetes & Endocrinology calling for new randomized clinical trials to investigate the safety risks of testosterone replacement therapy. Click here to read more.

April 11, 2014 — The European Medicines Agency (EMA) has opened areview of testosterone-containing medicines and they are demanding marketing information from drug-makers. Click here to read more.

March 12, 2014 — Another lawsuit has been filed by a man who used AndroGel (testosterone gel) and had a stroke. The lawsuit was filed on March 10 in the U.S. District Court for the Northern District of Illinois. Click here to read more.

March 6, 2014 — Endo Pharmaceuticals has received approval for Aveed (testosterone and castor oil injection), following three rejections from the FDA and a petition from consumer advocates to delay approval, citing concern about cardiovascular side effects. Click here to read more.

March 5, 2014 — The manufacturers of Testim (1% testosterone gel), Auxilium Pharmaceuticals, have been hit with a lawsuit from a man who suffered a stroke after using the testosterone replacement product. The lawsuit (.PDF) was filed in the U.S. District Court for the Central District of California on February 26. Click here to read more.

Activists Urge FDA to Add Black Box Warning on Testosterone

February 25, 2014 — The consumer advocacy group Public Citizen is calling on the FDA to add a Black Box warning label about cardiovascular risks of testosterone replacement products, calling the FDA inaction “reckless” and a “betrayal of its role in the U.S. Public Health Service.” Click here to read more.

FDA Investigates Testosterone Side Effects

March 4, 2015 — In a Safety Communication, the FDA is asking manufacturers of testosterone replacement products to stop marketing them for the treatment of age-related “Low T,” add warnings about heart attacks and strokes, and start studying the long-term risks. Click here to read more.

January 31, 2014 — The FDA has issued a Safety Communication to announce that they will investigate studies linking testosterone therapy to heart attacks, stroke, and death. The FDA has also reiterated that testosterone therapy is only FDA-approved for men with low testosterone and a serious medical condition, like hypogonadism, chemotherapy, or missing testicles. Click here to read more.

What is Testosterone?

Testosterone is an androgen, or male hormone. It is responsible for most male sexual characteristics, including body hair, muscle tone, and sperm production. After age 40, testosterone levels normally decrease by about 1% per year. Testosterone therapy is approved to treat low testosterone, a condition known as “hypogonadism,” which occurs when there is a problem in the brain or testicles that causes little or no testosterone production.

Symptoms of low testosterone:

  • Decreased libido (loss of interest in sex)
  • Erectile dysfunction
  • Fertility problems
  • Lack of energy
  • Depression
  • Decreased bone density, leading to brittle bones
  • Muscle weakness
  • Loss of body hair

Testosterone Treatments

The number of prescriptions for testosterone treatment has skyrocketed in recent years. Between 2000 and 2011, prescriptions jumped five-fold to 5.3 million prescriptions. Nearly 4% of men in their 60s use testosterone therapy, and three-quarters of them use a topical gel called AndroGel, manufactured by AbbVie.

Testosterone therapy products include:

  • Androgel (AbbVie Inc.) – Topical gel applied to skin
  • Androderm (Actavis) – Patch
  • Aveed (Endo Pharmaceuticals) – Intramuscular injection of testosterone and castor oil
  • Axiron (Lilly USA, LLC) – Underarm liquid/cream
  • Bio-T-Gel (Teva Pharmaceuticals) – Topical gel applied to skin
  • Delatestryl (Endo Pharmaceuticals) – Intramuscular injection
  • Depo-Testosterone (Unigen Life Sciences) – Injection
  • Fortesta (Endo Pharmaceuticlas) – Topical gel applied to skin
  • Natesto (Trimel Pharmaceuticals) – Nasal spray
  • Striant (Auxilium Pharmaceuticals) – Buccal tablet absorbed through gums
  • Testim (Auxilum Pharmaceuticals) – Topical gel applied to skin
  • Testopel (Auxilium Pharmaceuticals) – Subcutaneous pellet
  • Vogelxo (Upsher-Smith Laboratories) – Testosterone gel

Study Links Supplemental Testosterone and Heart Attacks

In January 2014, the journal PLoS One published a study on testosterone therapy and heart attacks. It tracked 56,000 older and middle-aged American men who were prescribed testosterone between 2008 and 2010. Researchers looked at the rate of heart attacks in the year before the prescriptions, versus three months after.

Findings were alarming — men 65 and older were twice as likely to have a heart attack after starting testosterone therapy. Men younger than 65 with a previous diagnosis of heart disease were three times as likely to have a heart attack. Click here to read more.

30% Increased Risk of Heart Attack from Testosterone Therapy

The study corroborates findings published in November 2013 in the Journal of the American Medical Association, in which researchers found that men over 60 years old were nearly 30% more likely to suffer a heart attack, stroke, or death after using testosterone.

Testosterone Therapy Side Effects

Need a Testosterone Lawyer in Texas?

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas testosterone lawyers for a free lawsuit review.